Patient Information Leaflet
Vitamin D3Farmasierra 1000 UI Tablets
Colecalciferol (Vitamin D3)
Read this leaflet carefully before you start taking this medicine. It contains important information for you.
-Keep this leaflet, as you may need to read it again.
-If you have any questions, ask your doctor or pharmacist.
-This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
-If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
1.What is Vitamin D3Farmasierra and what it is used for
2.What you need to know before taking Vitamin D3Farmasierra
3.How to take Vitamin D3Farmasierra
4.Possible side effects
5.Storage of Vitamin D3Farmasierra
6.Contents of the pack and additional information
This medication is recommended in the following cases:
-Treatment of vitamin D deficiency in adults and adolescents.
-Prevention of vitamin D deficiency in adults with identified risk.
-With other medications to treat certain bone disorders, such as bone thinning (osteoporosis) in adult patients with vitamin D deficiency or at risk of vitamin D insufficiency.
Do not take Vitamin D3Farmasierra
-if you are allergic to colecalciferol (Vitamin D3) or any of the other components of this medication (listed in section 6)
-if you have hypercalcemia (elevated calcium levels in the blood) or hypercalciuria (elevated calcium levels in the urine)
-if you have vitamin D toxicity (elevated vitamin D levels in the blood)
-if you have kidney stones
-if you have severe renal insufficiency (serious kidney problems)
Warnings and precautions
Consult your doctor or pharmacist before starting to take Vitamin D3:
-if you have sarcoidosis (a special type of connective tissue disease that affects the lungs, skin, and joints)
-if you have kidney problems or have had kidney stones
-if you have pseudohypoparathyroidism, a rare condition in which the body does not respond properly to the parathyroid hormone produced by the body
-when using this medication simultaneously with other medications that contain vitamin D
Taking Vitamin D3Farmasierra with food and drinks
Take Vitamin D3preferably with meals.
Children and adolescents
This medication is not recommended for use in children under 12 years old.
Other medications and Vitamin DD3Farmasierra
Inform your doctor or pharmacist that you are taking, have taken recently, or may need to take any other medication, particularly:
-Thiazide diuretics (to treat high blood pressure)
-Cardiac glycosides (to treat heart conditions), e.g. digoxin
-Glucocorticoids (to treat inflammation)
-Cholestyramine or cholestipol hydrochloride (used to treat high cholesterol)
-Paraffin oil laxatives
-Orlistat (weight loss)
-Magnesium (contained in some antacids)
-Phenytoin or barbiturates (used to treat epilepsy)
-Medications for the treatment of excess calcium (calcitonin, etidronate, gallium nitrate, pamidronate, or plicamycin)
-Rifampicin (antibiotic)
-Isoniazid (medication for tuberculosis)
-Actinomycin (chemotherapy)
-Imidazole (antifungal)
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Vitamin D3will only be used during pregnancy if a clinical deficiency of vitamin D has been diagnosed. During pregnancy, the daily intake of vitamin D should not exceed 400 UI.
Vitamin D3can be used during breastfeeding. Vitamin D3passes into breast milk. This should be taken into account when administering additional vitamin D to the infant.
Driving and operating machinery
Vitamin D3has no known effects on the ability to drive or operate machinery.
Warnings about excipients
If your doctor has told you that you are intolerant to certain sugars, consult with them before taking this medication.
Follow exactly the administration instructions indicated by your doctor. In case of doubts, consult your doctor or pharmacist again.
The patient's eating habits should be carefully evaluated and the vitamin D content of certain foods should be taken into account.foods
The tablets can be taken whole with water or crushed. It is recommended to take this medication preferably with a large meal so that your body can absorb vitamin D3.
Use in adults
After the first month, a lower maintenance dose should be considered.
Use in adolescents (12-18 years)
Higher doses should be considered based on medical criteria.
The initial treatment dose for vitamin D deficiency in adolescents should not exceed 4.000 UI/day (4 tablets/day)
Use in children
Vitamin D3Farmasierra is not intended for use in children under 12 years.
Administration form
The tablets can be taken whole with water or crushed.
If you take more Vitamina D3Farmasierra than you should
If you have taken a larger amount of this medication than prescribed, or if a child has accidentally taken this medication, contact your doctor or emergency services to evaluate the existing risk.
In case of overdose or accidental ingestion, consult the Toxicological Information Service, phone 91 562.04.20 indicating the medication and the amount used. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Vitamina D3Farmasierra
Do not take a double dose to compensate for the missed doses.
Take the missed dose as soon as possible; then return to your regular dosing schedule.
If it is almost time for the next dose, do not take the missed dose, just take the next dose normally.
If you interrupt the treatment with Vitamina D3Farmasierra
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, Vitamin D3can produce adverse effects, although not all people will experience them. If you consider that any of the adverse effects you are experiencing are severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
You must stop taking Vitamin D3immediately and consult with your doctor if you experience severe allergic reaction symptoms, such as:
Less Common Adverse Effects(occur in fewer than 1 in 100 patients): Hypercalcemia (elevated calcium levels in the blood) and hypercalciuria (elevated calcium levels in the urine).
Rare Adverse Effects(occur in fewer than 1 in 1,000 patients): Itching, skin rash, and hives.
Reporting Adverse Effects
If you experienceany type of adverse effect, consult your doctor or pharmacist or nurse, even if it is apossibleadverse effect not listed in this prospectus.You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.
By reporting adverse effects, you can contribute to providing more information about the safety of this medication.
Maintain this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box or in the container after the abbreviation CAD. The expiration date is the last day of the month indicated.
Store the tablets in their original packaging to protect them from light.
Store below 25 °C.
Medications should not be disposed of through drains or in the trash. Deposit the containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Vitamin D3Farmasierra
The active principle is colecalciferol:
Each tablet contains 1000 UI of vitamin D3, equivalent to 25 micrograms.
The other components are refined palm oil, hydrogenated palm oil, butylhydroxytoluene E321, isomaltose, anhydrous colloidal silica, microcrystalline cellulose, sodium croscarmellose, magnesium stearate.
Appearance of Vitamin D3Farmasierra and contents of the packaging
Vitamin D3 Farmasierra – round white-yellowish tablets.
It is presented in PVC/PVDC/PE blister packaging containing 30 tablets and conditioned in a cardboard box.
Holder of the Marketing Authorization
Farmasierra Laboratorios SL
Ctra de Irún km 26,200
28709 San Sebastián de los Reyes
Madrid
Spain
Responsible for manufacturing
Farmasierra Manufacturing SL
Ctra de Irún km 26,200
28709 San Sebastián de los Reyes
Madrid Spain
Last review date of this leaflet: September 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices AEMPShttp://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.